The human papillomavirus (HPV)-related cancer biology: An overview

•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are man...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 106; pp. 1537 - 1556
Main Authors Araldi, Rodrigo Pinheiro, Sant’Ana, Thalita Araujo, Módolo, Diego Grando, de Melo, Thatiana Correa, Spadacci-Morena, Diva Denelle, de Cassia Stocco, Rita, Cerutti, Janete Maria, de Souza, Edislane Barreiros
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are mandatory. Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20–25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2018.06.149